<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>Chapter 13 Population-level estimation | The Book of OHDSI</title>
  <meta name="description" content="This is a minimal example of using the bookdown package to write a book. The output format for this example is bookdown::gitbook." />
  <meta name="generator" content="bookdown 0.10.2 and GitBook 2.6.7" />

  <meta property="og:title" content="Chapter 13 Population-level estimation | The Book of OHDSI" />
  <meta property="og:type" content="book" />
  <meta property="og:url" content="https://ohdsi.github.io/TheBookOfOhdsi/" />
  <meta property="og:image" content="https://ohdsi.github.io/TheBookOfOhdsi/images/Cover/Cover.png" />
  <meta property="og:description" content="This is a minimal example of using the bookdown package to write a book. The output format for this example is bookdown::gitbook." />
  <meta name="github-repo" content="OHDSI/TheBookOfOhdsi" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Chapter 13 Population-level estimation | The Book of OHDSI" />
  
  <meta name="twitter:description" content="This is a minimal example of using the bookdown package to write a book. The output format for this example is bookdown::gitbook." />
  <meta name="twitter:image" content="https://ohdsi.github.io/TheBookOfOhdsi/images/Cover/Cover.png" />

<meta name="author" content="Observational Health Data Science and Informatics" />


<meta name="date" content="2019-05-24" />

  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="Characterization.html">
<link rel="next" href="PatientLevelPrediction.html">
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />







<!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-104086677-2"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-104086677-2');
</script>


<style type="text/css">
div.sourceCode { overflow-x: auto; }
table.sourceCode, tr.sourceCode, td.lineNumbers, td.sourceCode {
  margin: 0; padding: 0; vertical-align: baseline; border: none; }
table.sourceCode { width: 100%; line-height: 100%; }
td.lineNumbers { text-align: right; padding-right: 4px; padding-left: 4px; color: #aaaaaa; border-right: 1px solid #aaaaaa; }
td.sourceCode { padding-left: 5px; }
code > span.kw { color: #007020; font-weight: bold; } /* Keyword */
code > span.dt { color: #902000; } /* DataType */
code > span.dv { color: #40a070; } /* DecVal */
code > span.bn { color: #40a070; } /* BaseN */
code > span.fl { color: #40a070; } /* Float */
code > span.ch { color: #4070a0; } /* Char */
code > span.st { color: #4070a0; } /* String */
code > span.co { color: #60a0b0; font-style: italic; } /* Comment */
code > span.ot { color: #007020; } /* Other */
code > span.al { color: #ff0000; font-weight: bold; } /* Alert */
code > span.fu { color: #06287e; } /* Function */
code > span.er { color: #ff0000; font-weight: bold; } /* Error */
code > span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
code > span.cn { color: #880000; } /* Constant */
code > span.sc { color: #4070a0; } /* SpecialChar */
code > span.vs { color: #4070a0; } /* VerbatimString */
code > span.ss { color: #bb6688; } /* SpecialString */
code > span.im { } /* Import */
code > span.va { color: #19177c; } /* Variable */
code > span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code > span.op { color: #666666; } /* Operator */
code > span.bu { } /* BuiltIn */
code > span.ex { } /* Extension */
code > span.pp { color: #bc7a00; } /* Preprocessor */
code > span.at { color: #7d9029; } /* Attribute */
code > span.do { color: #ba2121; font-style: italic; } /* Documentation */
code > span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code > span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code > span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">The Book of OHDSI</a></li>

<li class="divider"></li>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Welcome</a></li>
<li class="part"><span><b>I The OHDSI Community</b></span></li>
<li class="chapter" data-level="1" data-path="MissionVissionValues.html"><a href="MissionVissionValues.html"><i class="fa fa-check"></i><b>1</b> Mission, vision, values</a><ul>
<li class="chapter" data-level="1.1" data-path="MissionVissionValues.html"><a href="MissionVissionValues.html#our-mission"><i class="fa fa-check"></i><b>1.1</b> Our Mission</a></li>
<li class="chapter" data-level="1.2" data-path="MissionVissionValues.html"><a href="MissionVissionValues.html#our-vision"><i class="fa fa-check"></i><b>1.2</b> Our Vision</a></li>
<li class="chapter" data-level="1.3" data-path="MissionVissionValues.html"><a href="MissionVissionValues.html#our-objectives"><i class="fa fa-check"></i><b>1.3</b> Our Objectives</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="Collaborators.html"><a href="Collaborators.html"><i class="fa fa-check"></i><b>2</b> Collaborators</a></li>
<li class="chapter" data-level="3" data-path="OpenScience.html"><a href="OpenScience.html"><i class="fa fa-check"></i><b>3</b> Open Science</a></li>
<li class="chapter" data-level="4" data-path="WhereToBegin.html"><a href="WhereToBegin.html"><i class="fa fa-check"></i><b>4</b> Where to begin</a></li>
<li class="part"><span><b>II Uniform Data Representation</b></span></li>
<li class="chapter" data-level="5" data-path="CommonDataModel.html"><a href="CommonDataModel.html"><i class="fa fa-check"></i><b>5</b> The Common Data Model</a><ul>
<li class="chapter" data-level="5.1" data-path="CommonDataModel.html"><a href="CommonDataModel.html#design-principles"><i class="fa fa-check"></i><b>5.1</b> Design Principles</a></li>
<li class="chapter" data-level="5.2" data-path="CommonDataModel.html"><a href="CommonDataModel.html#data-model-conventions"><i class="fa fa-check"></i><b>5.2</b> Data Model Conventions</a><ul>
<li class="chapter" data-level="5.2.1" data-path="CommonDataModel.html"><a href="CommonDataModel.html#model-conv"><i class="fa fa-check"></i><b>5.2.1</b> General conventions of the model</a></li>
<li class="chapter" data-level="5.2.2" data-path="CommonDataModel.html"><a href="CommonDataModel.html#general-conventions-of-schemas"><i class="fa fa-check"></i><b>5.2.2</b> General conventions of schemas</a></li>
<li class="chapter" data-level="5.2.3" data-path="CommonDataModel.html"><a href="CommonDataModel.html#general-conventions-of-data-tables"><i class="fa fa-check"></i><b>5.2.3</b> General conventions of data tables</a></li>
<li class="chapter" data-level="5.2.4" data-path="CommonDataModel.html"><a href="CommonDataModel.html#general-conventions-of-fields"><i class="fa fa-check"></i><b>5.2.4</b> General conventions of fields</a></li>
<li class="chapter" data-level="5.2.5" data-path="CommonDataModel.html"><a href="CommonDataModel.html#representation-of-content-through-concepts"><i class="fa fa-check"></i><b>5.2.5</b> Representation of content through Concepts</a></li>
<li class="chapter" data-level="5.2.6" data-path="CommonDataModel.html"><a href="CommonDataModel.html#difference-between-concept-ids-and-source-values"><i class="fa fa-check"></i><b>5.2.6</b> Difference between Concept IDs and Source Values</a></li>
</ul></li>
<li class="chapter" data-level="5.3" data-path="CommonDataModel.html"><a href="CommonDataModel.html#omop-cdm-standardized-tables"><i class="fa fa-check"></i><b>5.3</b> OMOP CDM Standardized Tables</a><ul>
<li class="chapter" data-level="5.3.1" data-path="CommonDataModel.html"><a href="CommonDataModel.html#running-example-endometriosis"><i class="fa fa-check"></i><b>5.3.1</b> Running Example: Endometriosis</a></li>
<li class="chapter" data-level="5.3.2" data-path="CommonDataModel.html"><a href="CommonDataModel.html#person"><i class="fa fa-check"></i><b>5.3.2</b> PERSON table</a></li>
<li class="chapter" data-level="5.3.3" data-path="CommonDataModel.html"><a href="CommonDataModel.html#observationPeriod"><i class="fa fa-check"></i><b>5.3.3</b> OBSERVATION_PERIOD table</a></li>
<li class="chapter" data-level="5.3.4" data-path="CommonDataModel.html"><a href="CommonDataModel.html#visitOccurrence"><i class="fa fa-check"></i><b>5.3.4</b> VISIT_OCCURRENCE</a></li>
<li class="chapter" data-level="5.3.5" data-path="CommonDataModel.html"><a href="CommonDataModel.html#conditionOccurrence"><i class="fa fa-check"></i><b>5.3.5</b> CONDITION_OCCURRENCE</a></li>
<li class="chapter" data-level="5.3.6" data-path="CommonDataModel.html"><a href="CommonDataModel.html#drugExposure"><i class="fa fa-check"></i><b>5.3.6</b> DRUG_EXPOSURE</a></li>
<li class="chapter" data-level="5.3.7" data-path="CommonDataModel.html"><a href="CommonDataModel.html#procedureOccurrence"><i class="fa fa-check"></i><b>5.3.7</b> PROCEDURE_OCCURRENCE</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="6" data-path="StandardizedVocabularies.html"><a href="StandardizedVocabularies.html"><i class="fa fa-check"></i><b>6</b> Standardized Vocabularies</a></li>
<li class="chapter" data-level="7" data-path="ExtractTransformLoad.html"><a href="ExtractTransformLoad.html"><i class="fa fa-check"></i><b>7</b> Extract Transform Load</a></li>
<li class="part"><span><b>III Data Analytics</b></span></li>
<li class="chapter" data-level="8" data-path="DataAnalyticsUseCases.html"><a href="DataAnalyticsUseCases.html"><i class="fa fa-check"></i><b>8</b> Data Analytics Use Cases</a></li>
<li class="chapter" data-level="9" data-path="OhdsiAnalyticsTools.html"><a href="OhdsiAnalyticsTools.html"><i class="fa fa-check"></i><b>9</b> OHDSI Analytics Tools</a></li>
<li class="chapter" data-level="10" data-path="SqlAndR.html"><a href="SqlAndR.html"><i class="fa fa-check"></i><b>10</b> SQL and R</a></li>
<li class="chapter" data-level="11" data-path="Cohorts.html"><a href="Cohorts.html"><i class="fa fa-check"></i><b>11</b> Building the building blocks: cohorts</a></li>
<li class="chapter" data-level="12" data-path="Characterization.html"><a href="Characterization.html"><i class="fa fa-check"></i><b>12</b> Characterization</a></li>
<li class="chapter" data-level="13" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html"><i class="fa fa-check"></i><b>13</b> Population-level estimation</a><ul>
<li class="chapter" data-level="13.1" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html#study-designs"><i class="fa fa-check"></i><b>13.1</b> Study designs</a><ul>
<li class="chapter" data-level="13.1.1" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html#cohort-method"><i class="fa fa-check"></i><b>13.1.1</b> Cohort method</a></li>
<li class="chapter" data-level="13.1.2" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html#self-controlled-cohort"><i class="fa fa-check"></i><b>13.1.2</b> Self-controlled cohort</a></li>
<li class="chapter" data-level="13.1.3" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html#case-control"><i class="fa fa-check"></i><b>13.1.3</b> Case-control</a></li>
<li class="chapter" data-level="13.1.4" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html#case-crossover"><i class="fa fa-check"></i><b>13.1.4</b> Case-crossover</a></li>
<li class="chapter" data-level="13.1.5" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html#self-controlled-case-series"><i class="fa fa-check"></i><b>13.1.5</b> Self-controlled case series</a></li>
</ul></li>
<li class="chapter" data-level="13.2" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html#cohort-study-implementation"><i class="fa fa-check"></i><b>13.2</b> Cohort study implementation</a><ul>
<li class="chapter" data-level="13.2.1" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html#implementation-using-atlas"><i class="fa fa-check"></i><b>13.2.1</b> Implementation using ATLAS</a></li>
<li class="chapter" data-level="13.2.2" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html#implementation-using-r"><i class="fa fa-check"></i><b>13.2.2</b> Implementation using R</a></li>
</ul></li>
<li class="chapter" data-level="13.3" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html#advanced-topics"><i class="fa fa-check"></i><b>13.3</b> Advanced topics</a></li>
<li class="chapter" data-level="13.4" data-path="PopulationLevelEstimation.html"><a href="PopulationLevelEstimation.html#excercises"><i class="fa fa-check"></i><b>13.4</b> Excercises</a></li>
</ul></li>
<li class="chapter" data-level="14" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html"><i class="fa fa-check"></i><b>14</b> Patient Level Prediction</a><ul>
<li class="chapter" data-level="14.1" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#study-specification"><i class="fa fa-check"></i><b>14.1</b> Study specification</a><ul>
<li class="chapter" data-level="14.1.1" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#problem-definition"><i class="fa fa-check"></i><b>14.1.1</b> Problem definition</a></li>
<li class="chapter" data-level="14.1.2" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#study-population-definition"><i class="fa fa-check"></i><b>14.1.2</b> Study population definition</a></li>
<li class="chapter" data-level="14.1.3" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#model-development-settings"><i class="fa fa-check"></i><b>14.1.3</b> Model development settings</a></li>
<li class="chapter" data-level="14.1.4" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#model-evaluation"><i class="fa fa-check"></i><b>14.1.4</b> Model evaluation</a></li>
<li class="chapter" data-level="14.1.5" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#study-summary"><i class="fa fa-check"></i><b>14.1.5</b> Study summary</a></li>
</ul></li>
<li class="chapter" data-level="14.2" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#study-implementation"><i class="fa fa-check"></i><b>14.2</b> Study implementation</a><ul>
<li class="chapter" data-level="14.2.1" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#cohort-instantiation"><i class="fa fa-check"></i><b>14.2.1</b> Cohort instantiation</a></li>
<li class="chapter" data-level="14.2.2" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#study-script-creation"><i class="fa fa-check"></i><b>14.2.2</b> Study script creation</a></li>
<li class="chapter" data-level="14.2.3" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#study-package-creation"><i class="fa fa-check"></i><b>14.2.3</b> Study package creation</a></li>
</ul></li>
<li class="chapter" data-level="14.3" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#internal-validation"><i class="fa fa-check"></i><b>14.3</b> Internal validation</a><ul>
<li class="chapter" data-level="14.3.1" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#discrimination"><i class="fa fa-check"></i><b>14.3.1</b> Discrimination</a></li>
<li class="chapter" data-level="14.3.2" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#calibration"><i class="fa fa-check"></i><b>14.3.2</b> Calibration</a></li>
<li class="chapter" data-level="14.3.3" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#smooth-calibration"><i class="fa fa-check"></i><b>14.3.3</b> Smooth Calibration</a></li>
<li class="chapter" data-level="14.3.4" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#preference-distribution"><i class="fa fa-check"></i><b>14.3.4</b> Preference distribution</a></li>
<li class="chapter" data-level="14.3.5" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#predicted-probability-distribution"><i class="fa fa-check"></i><b>14.3.5</b> Predicted probability distribution</a></li>
<li class="chapter" data-level="14.3.6" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#test-train-similarity"><i class="fa fa-check"></i><b>14.3.6</b> Test-Train similarity</a></li>
<li class="chapter" data-level="14.3.7" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#variable-scatter-plot"><i class="fa fa-check"></i><b>14.3.7</b> Variable scatter plot</a></li>
<li class="chapter" data-level="14.3.8" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#precision-recall"><i class="fa fa-check"></i><b>14.3.8</b> Precision recall</a></li>
<li class="chapter" data-level="14.3.9" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#demographic-summary"><i class="fa fa-check"></i><b>14.3.9</b> Demographic summary</a></li>
</ul></li>
<li class="chapter" data-level="14.4" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#external-validation"><i class="fa fa-check"></i><b>14.4</b> External validation</a></li>
<li class="chapter" data-level="14.5" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#journal-paper-generation"><i class="fa fa-check"></i><b>14.5</b> Journal paper generation</a></li>
<li class="chapter" data-level="14.6" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#other-functionality"><i class="fa fa-check"></i><b>14.6</b> Other functionality</a></li>
<li class="chapter" data-level="14.7" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#demos"><i class="fa fa-check"></i><b>14.7</b> Demos</a></li>
<li class="chapter" data-level="14.8" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#acknowledgments"><i class="fa fa-check"></i><b>14.8</b> Acknowledgments</a></li>
<li class="chapter" data-level="" data-path="PatientLevelPrediction.html"><a href="PatientLevelPrediction.html#appendix-1-study-population-settings-details"><i class="fa fa-check"></i>Appendix 1: Study population settings details</a></li>
</ul></li>
<li class="part"><span><b>IV Evidence Quality</b></span></li>
<li class="chapter" data-level="15" data-path="DataQuality.html"><a href="DataQuality.html"><i class="fa fa-check"></i><b>15</b> Data Quality</a><ul>
<li class="chapter" data-level="15.1" data-path="DataQuality.html"><a href="DataQuality.html#introduction"><i class="fa fa-check"></i><b>15.1</b> Introduction</a></li>
<li class="chapter" data-level="15.2" data-path="DataQuality.html"><a href="DataQuality.html#achilles-heel-tool"><i class="fa fa-check"></i><b>15.2</b> Achilles Heel tool</a><ul>
<li class="chapter" data-level="15.2.1" data-path="DataQuality.html"><a href="DataQuality.html#precomputed-analyses"><i class="fa fa-check"></i><b>15.2.1</b> Precomputed Analyses</a></li>
<li class="chapter" data-level="15.2.2" data-path="DataQuality.html"><a href="DataQuality.html#example-dq-check"><i class="fa fa-check"></i><b>15.2.2</b> Example DQ check</a></li>
<li class="chapter" data-level="15.2.3" data-path="DataQuality.html"><a href="DataQuality.html#overview-of-existing-dq-heel-checks"><i class="fa fa-check"></i><b>15.2.3</b> Overview of existing DQ Heel checks</a></li>
</ul></li>
<li class="chapter" data-level="15.3" data-path="DataQuality.html"><a href="DataQuality.html#study-specific-checks"><i class="fa fa-check"></i><b>15.3</b> Study-specific checks</a><ul>
<li class="chapter" data-level="15.3.1" data-path="DataQuality.html"><a href="DataQuality.html#outcomes"><i class="fa fa-check"></i><b>15.3.1</b> Outcomes</a></li>
<li class="chapter" data-level="15.3.2" data-path="DataQuality.html"><a href="DataQuality.html#laboratory-data"><i class="fa fa-check"></i><b>15.3.2</b> Laboratory data</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="16" data-path="SoftwareValidity.html"><a href="SoftwareValidity.html"><i class="fa fa-check"></i><b>16</b> Software Validity</a></li>
<li class="chapter" data-level="17" data-path="ClinicalValidity.html"><a href="ClinicalValidity.html"><i class="fa fa-check"></i><b>17</b> Clinical Validity</a></li>
<li class="chapter" data-level="18" data-path="MethodValidity.html"><a href="MethodValidity.html"><i class="fa fa-check"></i><b>18</b> Method Validity</a></li>
<li class="part"><span><b>V OHDSI Studies</b></span></li>
<li class="chapter" data-level="19" data-path="StudySteps.html"><a href="StudySteps.html"><i class="fa fa-check"></i><b>19</b> Study steps</a></li>
<li class="chapter" data-level="20" data-path="NetworkResearch.html"><a href="NetworkResearch.html"><i class="fa fa-check"></i><b>20</b> OHDSI Network Research</a><ul>
<li class="chapter" data-level="20.1" data-path="NetworkResearch.html"><a href="NetworkResearch.html#ohdsi-network-study-examples"><i class="fa fa-check"></i><b>20.1</b> OHDSI Network Study Examples</a><ul>
<li class="chapter" data-level="20.1.1" data-path="NetworkResearch.html"><a href="NetworkResearch.html#endometriosis-study"><i class="fa fa-check"></i><b>20.1.1</b> Endometriosis study</a></li>
</ul></li>
<li class="chapter" data-level="20.2" data-path="NetworkResearch.html"><a href="NetworkResearch.html#excercises-1"><i class="fa fa-check"></i><b>20.2</b> Excercises</a><ul>
<li class="chapter" data-level="20.2.1" data-path="NetworkResearch.html"><a href="NetworkResearch.html#defining-a-cohort"><i class="fa fa-check"></i><b>20.2.1</b> Defining a cohort</a></li>
</ul></li>
</ul></li>
<li class="appendix"><span><b>Appendix</b></span></li>
<li class="chapter" data-level="A" data-path="Glossary.html"><a href="Glossary.html"><i class="fa fa-check"></i><b>A</b> Glossary</a></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">The Book of OHDSI</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="PopulationLevelEstimation" class="section level1">
<h1><span class="header-section-number">Chapter 13</span> Population-level estimation</h1>
<p><em>Chapter leads: Martijn Schuemie, David Madigan &amp; Marc Suchard</em></p>
<p>Observational healthcare data, such as administrative claims and electronic health records, offer opportunities to generate real-world evidence about the effect of treatments that can meaningfully improve the lives of patients. In this chapter we focus on population-level effect estimation, that is, the estimation of average causal effects of medical interventions on specific health outcomes of interest. In what follows, we consider two different estimation tasks:</p>
<ul>
<li><em>Direct effect estimation</em>: estimating the effect of an exposure on the risk of an outcome, as compared to no exposure.</li>
<li><em>Comparative effect estimation</em>: estimation the effect of one exposure (the target exposure) on the risk of an outcome, as compared to another exposure (the comparator exposure).</li>
</ul>
<p>In both cases, the patient-level causal effect contrasts a factual outcome, i.e., what happened to the exposed patient, with a counterfactual outcome, i.e., what would have happened had the exposure not occurred (direct) or had a different exposure occurred (comparative). Since any one patient reveals only the factual outcome (the fundamental problem of causal inference), the various effect estimation methods employ analytic devices to shed light on the counterfactual outcomes.</p>
<p>Use-cases for population-level effect estimation include treatment selection, safety surveillance, and comparative effectiveness. Methods can test specific hypotheses one-at-a-time (e.g. ‘signal evaluation’) or explore multiple-hypotheses-at-once (e.g. ‘signal detection’). In all cases, the objective remains the same: to produce a high-quality estimate of the causal effect.</p>
<div id="study-designs" class="section level2">
<h2><span class="header-section-number">13.1</span> Study designs</h2>
<p>Several different study designs can be used to estimate treatment effects. The main difference between these is how they construct the (unobserved) counterfactual. Below is a brief discussion of the most commonly used designs, all of which are implemented as R packages in the OHDSI Methods Library.</p>
<div id="cohort-method" class="section level3">
<h3><span class="header-section-number">13.1.1</span> Cohort method</h3>
<div class="figure"><span id="fig:cohortMethod"></span>
<img src="images/PopulationLevelEstimation/cohortMethod.png" alt="The new-user cohort design. Subjects observed to initiate the target treatment are compared to those initiating the comparator treatment. To adjust for differences between the two treatment groups several adjustment strategies can be used, such as stratification, matching, or weighting by the propensity score, or by adding baseline characateristcs to the outcome model. The chararacteristics included in the propensity model or outcome model are captured prior to treatment initiation." width="90%" />
<p class="caption">
Figure 13.1: The new-user cohort design. Subjects observed to initiate the target treatment are compared to those initiating the comparator treatment. To adjust for differences between the two treatment groups several adjustment strategies can be used, such as stratification, matching, or weighting by the propensity score, or by adding baseline characateristcs to the outcome model. The chararacteristics included in the propensity model or outcome model are captured prior to treatment initiation.
</p>
</div>
<p>The new-user cohort method attempts to emulate a randomized clinical trial <span class="citation">(Hernan and Robins <a href="#ref-hernan_2016">2016</a>)</span>. Subjects that are observed to initiate one treatment (the target) are compared to subjects initiating another treatment (the comparator) and are followed for a specific amount of time following treatment initiation, for example the time they stay on the treatment. One crucial difference with a randomized trial is that there is no randomization, and therefore there might be systematic differences between the target and comparator populations. Without adjusting for these differences, estimates are likely to be confounded. A popular mechanism for adjusting for confounding is the use of Propensity Scores (PS). The PS is the probability of a subject receiving one treatment instead of the other, conditional on baseline characteristics. <span class="citation">(Rosenbaum and Rubin <a href="#ref-rosenbaum_1983">1983</a>)</span> First, a model – typically a logistic regression – is fitted using the observed treatment assignments (target or comparator), then the model is used to produce the PS for each subject. In the past, PS were computed based on manually selected characteristics, and although the CohortMethod package can support such practices, we prefer the use of large-scale regularized regression using many generic characteristics. <span class="citation">(Tian, Schuemie, and Suchard <a href="#ref-tian_2018">2018</a>)</span> These characteristics include demographics, as well as all diagnoses, drug exposures, measurement, and medical procedures observed prior to treatment initiation, and exclude the target and comparator treatment. A model typically involves 10,000 to 100,000 unique characteristics. The PS can be used in several ways, for example by stratifying the study population based on the PS, by matching target subjects to comparator subjects with similar PS, or by weighting subjects using Inverse Probability of Treatment Weighting (IPTW) derived from the PS. Another strategy for adjusting for differences between the two groups is to include additional variables in the outcome model. One major limitation of this approach is that whereas there often is a wealth of data to fit a propensity model, with thousands of people in both treatment groups, the outcomes we study tend to be somewhat rare, causing a paucity of data when trying to fit elaborate models with the outcome as dependent variable. One approach is to use both a PS and add the same variables that were used in the propensity model in the outcome model, thus adjusting for the same variables twice, but in different ways. The new-user cohort method inherently is a method for comparative effect estimation, comparing one treatment to another. It is difficult to use this method to compare a treatment against no treatment, since it is hard to define a group of unexposed people that is comparable with the exposed group. If one wants to use this design for direct effect estimation, the preferred way is to select a comparator treatment for the same indication as the exposure of interest, where the comparator treatment is believed to have no effect on the outcome. Unfortunately, such a comparator might not always be available. In our gold standard, the comparators were specifically selected to have no effect, so we can also evaluate the cohort method’s performance for direct effect estimation.</p>
</div>
<div id="self-controlled-cohort" class="section level3">
<h3><span class="header-section-number">13.1.2</span> Self-controlled cohort</h3>
<div class="figure"><span id="fig:scc"></span>
<img src="images/PopulationLevelEstimation/selfControlledCohort.png" alt="The self-controlled cohort design. The rate of outcomes during exposure to the target is compared to the rate of outcomes in the time pre-exposure. ." width="90%" />
<p class="caption">
Figure 13.2: The self-controlled cohort design. The rate of outcomes during exposure to the target is compared to the rate of outcomes in the time pre-exposure. .
</p>
</div>
<p>The self-controlled cohort (SCC) design <span class="citation">(P. B. Ryan, Schuemie, and Madigan <a href="#ref-ryan_2013">2013</a>)</span> compares the rate of outcomes during exposure to the rate of outcomes in the time just prior to the exposure. Because the same subject that make up the exposed group are also used as the control group, no adjustment for between-person differences need to be made. However, the method is vulnerable to other differences, such as differences between different time periods.</p>
</div>
<div id="case-control" class="section level3">
<h3><span class="header-section-number">13.1.3</span> Case-control</h3>
<div class="figure"><span id="fig:caseControl"></span>
<img src="images/PopulationLevelEstimation/caseControl.png" alt="The case-control design. Subjects with the outcome (‘cases’) are compared to subjects without the outcome (‘controls’) in terms of their exposure status. Often, cases and controls are matched on various characteristics such as age and sex." width="90%" />
<p class="caption">
Figure 13.3: The case-control design. Subjects with the outcome (‘cases’) are compared to subjects without the outcome (‘controls’) in terms of their exposure status. Often, cases and controls are matched on various characteristics such as age and sex.
</p>
</div>
<p>Case-control <span class="citation">(Vandenbroucke and Pearce <a href="#ref-vandenbroucke_2012">2012</a>)</span> studies consider the question “are persons with a specific disease outcome exposed more frequently to a specific agent than those without the disease?” Thus, the central idea is to compare “cases”, i.e., subjects that experience the outcome of interest with “controls”, i.e., subjects that did not experience the outcome of interest. Often, one matches controls to cases based on characteristics such as age and sex to make them more comparable. Another widespread practice is to nest the analysis within a specific subgroup of people, for example people that have all been diagnosed with one of the indications of the exposure of interest.</p>
</div>
<div id="case-crossover" class="section level3">
<h3><span class="header-section-number">13.1.4</span> Case-crossover</h3>
<div class="figure"><span id="fig:caseCrossover"></span>
<img src="images/PopulationLevelEstimation/caseCrossover.png" alt="The case-crossover design. The time around the outcome is compared to a control date set at a predefined interval prior to the outcome date." width="90%" />
<p class="caption">
Figure 13.4: The case-crossover design. The time around the outcome is compared to a control date set at a predefined interval prior to the outcome date.
</p>
</div>
<p>The case-crossover <span class="citation">(Maclure <a href="#ref-maclure_1991">1991</a>)</span> design evaluates whether the rate of exposure is different at the time of the outcome than at some predefined number of days prior to the outcome. It is trying to determine whether there is something special about the day the outcome occurred. Since cases serve as their own control, it is a self-controlled design, and should therefore be robust to confounding due to between-person differences. One concern is that, because the outcome date is always later than the control date, the method will be positively biased if the overall frequency of exposure increases over time (or negatively biased if there is a decrease). To address this, the case-time-control design <span class="citation">(Suissa <a href="#ref-suissa_1995">1995</a>)</span> was developed, which adds matched controls to the case-crossover design to adjust for exposure trends.</p>
</div>
<div id="self-controlled-case-series" class="section level3">
<h3><span class="header-section-number">13.1.5</span> Self-controlled case series</h3>
<div class="figure"><span id="fig:selfControlledCaseSeries"></span>
<img src="images/PopulationLevelEstimation/selfControlledCaseSeries.png" alt="The Self-Controlled Case Series design. The rate of outcomes during exposure is compared to the rate of outcomes when not exposed." width="90%" />
<p class="caption">
Figure 13.5: The Self-Controlled Case Series design. The rate of outcomes during exposure is compared to the rate of outcomes when not exposed.
</p>
</div>
<p>The Self-Controlled Case Series (SCCS) design <span class="citation">(C. P. Farrington <a href="#ref-farrington_1995">1995</a>,whitaker_2006)</span> compares the rate of outcomes during exposure to the rate of outcomes during all unexposed time, both before, between, and after exposures. It is a Poisson regression that is conditioned on the person. Thus, it seeks to answer the question: “Given that a patient has the outcome, is the outcome more likely during exposed time compared to non-exposed time?” Like other self-controlled designs, the SCCS is robust to confounding due to between-person differences, but vulnerable to confounding due to time-varying effects. Several adjustments are possible to attempt to account for these, for example by including age and season. A special variant of the SCCS includes not just the exposure of interest, but all other exposures to drugs recorded in the database <span class="citation">(Simpson et al. <a href="#ref-simpson_2013">2013</a>)</span>, potentially adding thousands of additional variables to the model. L1-regularization using cross-validation to select the regularization hyperparameter is applied to the coefficients of all exposures except the exposure of interest.</p>
<p>One important assumption underlying the SCCS is that the observation period end is independent of the date of the outcome. Because for some outcomes, especially ones that can be fatal such as stroke, this assumption can be violated an extension to the SCCS has been developed that corrects for any such dependency. <span class="citation">(C. Paddy Farrington et al. <a href="#ref-farrington_2011">2011</a>)</span></p>
</div>
</div>
<div id="cohort-study-implementation" class="section level2">
<h2><span class="header-section-number">13.2</span> Cohort study implementation</h2>
<p>Describe case study: risk of angioedema and AMI in new users of ACE inhibitors compared to new users of thiazide and thiazide-like diuretics</p>
<p>Template: T, C, O, time-at-risk, model</p>
<div id="implementation-using-atlas" class="section level3">
<h3><span class="header-section-number">13.2.1</span> Implementation using ATLAS</h3>
</div>
<div id="implementation-using-r" class="section level3">
<h3><span class="header-section-number">13.2.2</span> Implementation using R</h3>
</div>
</div>
<div id="advanced-topics" class="section level2">
<h2><span class="header-section-number">13.3</span> Advanced topics</h2>
<p>Best practices: <a href="http://www.ohdsi.org/web/wiki/doku.php?id=development:best_practices_estimation" class="uri">http://www.ohdsi.org/web/wiki/doku.php?id=development:best_practices_estimation</a></p>
<p>Negative and positive controls, empirical calibration</p>
</div>
<div id="excercises" class="section level2">
<h2><span class="header-section-number">13.4</span> Excercises</h2>

</div>
</div>
<h3>References</h3>
<div id="refs" class="references">
<div id="ref-farrington_1995">
<p>Farrington, C. P. 1995. “Relative incidence estimation from case series for vaccine safety evaluation.” <em>Biometrics</em> 51 (1): 228–35.</p>
</div>
<div id="ref-farrington_2011">
<p>Farrington, C. Paddy, Karim Anaya-Izquierdo, Heather J. Whitaker, Mounia N. Hocine, Ian Douglas, and Liam Smeeth. 2011. “Self-Controlled Case Series Analysis with Event-Dependent Observation Periods.” <em>Journal of the American Statistical Association</em> 106 (494). Taylor &amp; Francis: 417–26. doi:<a href="https://doi.org/10.1198/jasa.2011.ap10108">10.1198/jasa.2011.ap10108</a>.</p>
</div>
<div id="ref-hernan_2016">
<p>Hernan, M. A., and J. M. Robins. 2016. “Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.” <em>Am. J. Epidemiol.</em> 183 (8): 758–64.</p>
</div>
<div id="ref-maclure_1991">
<p>Maclure, M. 1991. “The case-crossover design: a method for studying transient effects on the risk of acute events.” <em>Am. J. Epidemiol.</em> 133 (2): 144–53.</p>
</div>
<div id="ref-rosenbaum_1983">
<p>Rosenbaum, P., and D. Rubin. 1983. “The Central Role of the Propensity Score in Observational Studies for Causal Effects.” <em>Biometrika</em> 70 (April): 41–55. doi:<a href="https://doi.org/10.1093/biomet/70.1.41">10.1093/biomet/70.1.41</a>.</p>
</div>
<div id="ref-ryan_2013">
<p>Ryan, P. B., M. J. Schuemie, and D. Madigan. 2013. “Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system.” <em>Drug Saf</em> 36 Suppl 1 (October): 95–106.</p>
</div>
<div id="ref-simpson_2013">
<p>Simpson, S. E., D. Madigan, I. Zorych, M. J. Schuemie, P. B. Ryan, and M. A. Suchard. 2013. “Multiple self-controlled case series for large-scale longitudinal observational databases.” <em>Biometrics</em> 69 (4): 893–902.</p>
</div>
<div id="ref-suissa_1995">
<p>Suissa, S. 1995. “The case-time-control design.” <em>Epidemiology</em> 6 (3): 248–53.</p>
</div>
<div id="ref-tian_2018">
<p>Tian, Y., M. J. Schuemie, and M. A. Suchard. 2018. “Evaluating large-scale propensity score performance through real-world and synthetic data experiments.” <em>Int J Epidemiol</em> 47 (6): 2005–14.</p>
</div>
<div id="ref-vandenbroucke_2012">
<p>Vandenbroucke, J. P., and N. Pearce. 2012. “Case-control studies: basic concepts.” <em>Int J Epidemiol</em> 41 (5): 1480–9.</p>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="Characterization.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="PatientLevelPrediction.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"google": false,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"all": ["facebook", "google", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/OHDSI/TheBookOfOhdsi/edit/master/PopulationLevelEstimation.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"download": ["TheBookOfOhdsi.pdf", "TheBookOfOhdsi.epub"],
"toc": {
"collapse": "section"
}
});
});
</script>

</body>

</html>
